Note: This webinar took place on 5 July 2017. You can find a video recording and the presentations used during the webinar below. Webinar introduction A very important result from the EUPATI project was the development, broad consultation and final release of guidances on the best approach to interaction of patients with pharmaceutical industry-led medicines R&D, regulatory…Read more
Health Technology Assessment is gaining importance in regulatory decisions about the registration and reimbursement of health technologies in a growing number of European states. It is essential to involve patients in this process, and not only because the law requires such involvement in many countries, but also because evidence shows that patients who are informed…Read more
HTA is a multidisciplinary process that examines the information about medical, cost-effectiveness, social, political, legal and ethical considerations of the application of a health technology – usually a medicine, medical device or clinical/surgical procedure. The main purpose of conducting an assessment is to inform policy decision making, which has an impact on patients and their ecosystem of health, including physicians and payers.
The webinar will examine the need for patient involvement in HTA and look at the HTA landscape in Europe. A patient organisation representative will present a case study on patient participation in HTA, and the conversation will also look at how the EUPATI toolkit can help informed patients engage in HTA.